ESC 365 - Implementing cardiac biomarkers in clinical practice: insights from risk stratification with high-sensitivity troponin in asymptomatic individuals

Open Access

Implementing cardiac biomarkers in clinical practice: insights from risk stratification with high-sensitivity troponin in asymptomatic individuals

Session: Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

Topic: Prevention

Speaker: Associate Professor B. Abramson (Toronto, CA)

Sponsored by Abbott laboratories

Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

About the speaker

Associate Professor Beth Lynn Abramson

St. Michael's Hospital, Toronto (Canada)

1 presentation

0 follower

3 more presentations in this session

Welcome and introduction

Speaker: Associate Professor D. Farmakis (Athens, GR)

Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers

Speaker: Doctor D. Kimenai (Edinburgh, GB)

Discussion - Q&A

Access the full session

Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

Speakers: Associate Professor B. Abramson, Associate Professor D. Farmakis, Doctor D. Kimenai

About the event

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources